Vaso-Occlusive Pain Episode in Sickle Cell Disease Clinical Trials
2 recruiting trials for Vaso-Occlusive Pain Episode in Sickle Cell Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Vaso-Occlusive Pain Episode in Sickle Cell Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 4 is the largest group at 50% (1 studies); the largest phase groups are Phase 4: 1, Phase 2: 1.
Research is led by University of Pennsylvania (1), Mohsen Saidinejad (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Depot medroxyprogesterone acetate (DMPA) (drug, 1 trial), followed by Sub-dissociative Ketamine Infusion, Normal Saline Placebo Infusion.
Track Vaso-Occlusive Pain Episode in Sickle Cell Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
This research is being conducted to see if using an injectable contraception, Depot Medroxyprogesterone Acetate (Depo-Provera), can reduce the pain experienced by women with...
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
The purpose of this research is to see if ketamine is effective and safe in treating children and young adults with sickle cell disease experiencing sickle cell related pain. In...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Vaso-Occlusive Pain Episode in Sickle Cell Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Vaso-Occlusive Pain Episode in Sickle Cell Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Vaso-Occlusive Pain Episode in Sickle Cell Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.